Omeros Corp (OMER): Next-Year EPS Estimate 34.02%
As of 2026-05-27, Omeros Corp (OMER) has a next-year EPS growth estimate of 34.02%.
On 2026-05-17, analyst consensus for OMER's next-year EPS growth shifted from 164.69% to 34.02% — a negative change of 130.67 percentage points. The revised estimate has been sustained across 9 subsequent trading sessions. Current-year growth is projected at 506.67%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 34.02%
- EPS growth this year
- 506.67%
- EPS next quarter (est)
- -$0.25
- Last price
- $11.07
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-27 | 34.02% | 506.67% | -$0.25 | $11.07 |
| 2026-05-26 | 34.02% | 506.67% | -$0.25 | $11.65 |
| 2026-05-25 | 34.02% | 506.67% | -$0.25 | $11.46 |
| 2026-05-24 | 34.02% | 506.67% | -$0.25 | $11.46 |
| 2026-05-21 | 34.02% | 506.67% | -$0.25 | $11.96 |
| 2026-05-20 | 34.02% | 506.67% | -$0.25 | $12.38 |
| 2026-05-19 | 34.02% | 506.67% | -$0.25 | $11.97 |
| 2026-05-18 | 34.02% | 506.67% | -$0.25 | $11.70 |
| 2026-05-17 | 34.02% | 506.67% | -$0.25 | $12.25 |
| 2026-05-14 | 164.69% | -433.33% | -$0.29 | $13.28 |
| 2026-05-13 | 182.71% | -1712.13% | -$0.39 | $14.69 |
| 2026-05-12 | 194.53% | -1485.60% | -$0.30 | $14.76 |
| 2026-05-11 | 194.53% | -1485.60% | -$0.30 | $14.36 |
| 2026-05-10 | 194.53% | -1485.60% | -$0.30 | $14.13 |
| 2026-05-07 | 194.53% | -1485.60% | -$0.30 | $14.64 |
| 2026-05-06 | 194.53% | -1485.60% | -$0.30 | $14.83 |
| 2026-05-05 | 194.53% | -1485.60% | -$0.30 | $14.77 |
| 2026-05-04 | 194.53% | -1485.60% | -$0.30 | $14.91 |
| 2026-05-03 | 194.53% | -1485.60% | -$0.30 | $15.06 |
| 2026-04-30 | 194.53% | -1485.60% | -$0.30 | $14.60 |
| 2026-04-29 | 194.53% | -1485.60% | -$0.30 | $14.56 |
| 2026-04-28 | 194.53% | -1485.60% | -$0.30 | $14.67 |
| 2026-04-27 | 194.53% | -1485.60% | -$0.30 | $14.74 |
| 2026-04-26 | 194.53% | -1485.60% | -$0.30 | $13.53 |
| 2026-04-24 | 194.53% | -1485.60% | -$0.30 | $13.53 |
| 2026-04-23 | 194.53% | -1485.60% | -$0.30 | $13.52 |
| 2026-04-22 | 194.53% | -1485.60% | -$0.30 | $13.37 |
| 2026-04-21 | 194.54% | -1486.67% | -$0.30 | $13.26 |
| 2026-04-20 | 147.73% | 760.00% | $0.02 | $13.47 |
| 2026-04-19 | 147.73% | 760.00% | $0.02 | $13.44 |
Recent News
- Omeros Corp (OMER) Q1 2026 Earnings Call Highlights: Strong YARTEMLEA Launch and Strategic ...GuruFocus.com
- Omeros Corporation Q4 2025 Earnings Call SummaryMoby
- Omeros Corp (OMER) Q4 2025 Earnings Call Highlights: A Turnaround with Strategic Deals and FDA ...GuruFocus.com
- Omeros: Q4 Earnings SnapshotAssociated Press
- Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial ResultsBusiness Wire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Omeros Corp's next-year EPS growth estimate?▾
As of 2026-05-27, Omeros Corp (OMER) has a next-year EPS growth estimate of 34.02%, based on analyst consensus.
When was the latest EPS estimate revision for OMER?▾
The most recent revision occurred on 2026-05-17, when analysts adjusted the next-year EPS growth estimate from 164.69% to 34.02%.
What sector and industry does Omeros Corp belong to?▾
Omeros Corp operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. OMER appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Omeros Corp (OMER) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports